Diagnostic delay for giant cell arteritis – a systematic review and meta-analysis
Open Access
- 28 June 2017
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 15 (1) , 1-12
Abstract
Giant cell arteritis (GCA), if untreated, can lead to blindness and stroke. The study’s objectives were to (1) determine a new evidence-based benchmark of the extent of diagnostic delay for GCA and (2) examine the role of GCA-specific characteristics on diagnostic delay. Medical literature databases were searched from inception to November 2015. Articles were included if reporting a time-period of diagnostic delay between onset of GCA symptoms and diagnosis. Two reviewers assessed the quality of the final articles and extracted data from these. Random-effects meta-analysis was used to pool the mean time-period (95% confidence interval (CI)) between GCA symptom onset and diagnosis, and the delay observed for GCA-specific characteristics. Heterogeneity was assessed by I 2 and by 95% prediction interval (PI). Of 4128 articles initially identified, 16 provided data for meta-analysis. Mean diagnostic delay was 9.0 weeks (95% CI, 6.5 to 11.4) between symptom onset and GCA diagnosis (I 2 = 96.0%; P < 0.001; 95% PI, 0 to 19.2 weeks). Patients with a cranial presentation of GCA received a diagnosis after 7.7 (95% CI, 2.7 to 12.8) weeks (I 2 = 98.4%; P < 0.001; 95% PI, 0 to 27.6 weeks) and those with non-cranial GCA after 17.6 (95% CI, 9.7 to 25.5) weeks (I 2 = 96.6%; P < 0.001; 95% PI, 0 to 46.1 weeks). The mean delay from symptom onset to GCA diagnosis was 9 weeks, or longer when cranial symptoms were absent. Our research provides an evidence-based benchmark for diagnostic delay of GCA and supports the need for improved public awareness and fast-track diagnostic pathways.Keywords
Funding Information
- National Institute for Health Research (NIHR-RP-2014-04-026)
- Inspire Foundation
- NIHR Clinical Lectureship in General Practice
- NIHR Clinician Scientist Fellowship award
This publication has 54 references indexed in Scilit:
- The epidemiology of malpractice claims in primary care: a systematic reviewBMJ Open, 2013
- Diagnosis and management of giant cell arteritisBritish Journal of General Practice, 2012
- Polymyalgia rheumatica and giant cell arteritis: An in‐depth look at diagnosis and treatmentJournal of the American Academy of Nurse Practitioners, 2012
- Sonographic and clinical pattern of extracranial and cranial giant cell arteritisScandinavian Journal of Rheumatology, 2012
- Delays in assessment of patients with rheumatoid arthritis: variations across EuropeAnnals of the Rheumatic Diseases, 2011
- Delays in recognition and management of giant cell arteritis: results from a retrospective auditClinical Rheumatology, 2010
- Analysis of temporal artery biopsies in an 18-year period at a community hospitalEuropean Journal of Internal Medicine, 2009
- Risk factors for early visual deterioration in temporal arteritisJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001Annals of the Rheumatic Diseases, 2006
- Giant cell arteritis without clinically evident vascular involvement in a defined populationArthritis Care & Research, 2004